ELI LILLY & Co is 1134.4x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $945.18 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRVS | LLY |
|---|---|---|
| Market cap | $945.18 M | $1.072 T |
| US-listed rank | #2651 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$15.30M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 570 | 989 |
ELI LILLY & Co is 1134.4x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $945.18 M).
Full pages: Corvus Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.